📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection. (2022)

First Author: Sokhela S

Attributed to: New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkac266

PubMed Identifier: 35953881

Publication URI: http://europepmc.org/abstract/MED/35953881

Type: Journal Article/Review

Volume: 77

Parent Publication: The Journal of antimicrobial chemotherapy

Issue: 10

ISSN: 0305-7453